Shinji Nakao Selected Research

Shinji Nakao Research Topics

Disease

55	Aplastic Anemia (Anemia, Hypoplastic) 12/2023 - 12/2002
29	Neoplasms (Cancer) 05/2024 - 10/2002
17	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023 - 12/2002
17	Leukemia 01/2017 - 08/2002
16	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 10/2002
14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 10/2004
14	Disseminated Intravascular Coagulation 11/2017 - 01/2002
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 05/2003
12	Infections 05/2024 - 09/2003
12	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2004
11	Bone Marrow Failure Disorders 08/2021 - 12/2002
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2018 - 12/2002
11	Lymphoma (Lymphomas) 01/2016 - 01/2003
10	Asthma (Bronchial Asthma) 06/2009 - 04/2002
9	Multiple Myeloma 06/2023 - 07/2007
9	Cough 04/2020 - 12/2004
8	Anemia 01/2022 - 03/2003
7	Febrile Neutropenia 05/2024 - 03/2009
7	Fever (Fevers) 12/2020 - 06/2002
7	Thrombocytopenia (Thrombopenia) 01/2017 - 12/2002
6	Hemolysis 01/2023 - 01/2011
6	Residual Neoplasm 01/2021 - 08/2006
6	Fibrosis (Cirrhosis) 01/2017 - 05/2008
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2012 - 06/2002
6	Inflammation (Inflammations) 06/2009 - 09/2002
5	Dyspnea (Shortness of Breath) 01/2012 - 12/2004
5	Renal Cell Carcinoma (Grawitz Tumor) 12/2009 - 09/2003
4	Disease Progression 03/2024 - 09/2006
4	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2004
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 08/2006
4	Edema (Dropsy) 01/2017 - 09/2006
4	Hemorrhage 03/2012 - 09/2005
4	Cough-Variant Asthma 06/2010 - 12/2004
3	Hepatitis 11/2023 - 06/2011
3	Bronchiolitis Obliterans 01/2019 - 11/2007
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 01/2005
3	Multi-centric Castleman's Disease 01/2017 - 01/2013
3	Pure Red-Cell Aplasia 04/2016 - 08/2007
3	Myeloid Leukemia (Leukemia, Myelocytic) 01/2015 - 03/2007
3	Philadelphia Chromosome 09/2012 - 08/2006
3	Abdominal Aortic Aneurysm 10/2009 - 09/2005

Drug/Important Bio-Agent (IBA)

19	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2023 - 10/2002
17	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2004
14	AntigensIBA 01/2022 - 01/2002
13	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 11/2023 - 12/2002
13	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2023 - 05/2003
13	Dacarbazine (DIC)FDA LinkGeneric 11/2017 - 10/2002
12	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2024 - 02/2005
9	CytokinesIBA 02/2017 - 10/2002
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2023 - 06/2002
8	AntibodiesIBA 01/2021 - 10/2004
8	LipopolysaccharidesIBA 10/2006 - 01/2002
7	Methacholine Chloride (Methacholine)FDA Link 12/2018 - 12/2002
7	Rituximab (Mabthera)FDA Link 01/2016 - 05/2005
6	eculizumab FDA Link 01/2023 - 01/2011
6	eltrombopag FDA Link 11/2022 - 08/2019
6	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 02/2007
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 08/2006
6	AutoantibodiesIBA 01/2022 - 03/2007
6	Imatinib Mesylate (Gleevec)FDA Link 02/2017 - 10/2004
6	Thromboplastin (Tissue Factor)IBA 03/2012 - 01/2002
6	Bronchodilator Agents (Bronchodilators)IBA 06/2010 - 04/2003
5	Immunoglobulin G (IgG)IBA 01/2017 - 09/2005
5	Gefitinib (Iressa)FDA Link 09/2012 - 01/2004
5	Hemostatics (Antihemorrhagics)IBA 03/2012 - 01/2002
4	HLA-DR15 antigenIBA 10/2023 - 12/2002
4	Complement Inactivating AgentsIBA 01/2023 - 01/2011
4	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 05/2005
4	fludarabineIBA 01/2022 - 09/2003
4	SteroidsIBA 12/2020 - 04/2003
4	Complement System Proteins (Complement)IBA 01/2019 - 01/2006
4	ErbB Receptors (EGF Receptor)IBA 03/2018 - 01/2004
4	ResveratrolIBA 01/2017 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 10/2013 - 03/2006
4	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2011 - 09/2007
4	moesinIBA 12/2010 - 03/2007
4	Tranexamic Acid (AMCA)FDA Link 11/2005 - 06/2004
3	romiplostim FDA Link 12/2023 - 01/2021
3	Nerve Growth Factor (NGF)IBA 02/2023 - 04/2019
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 06/2010
3	ravulizumabIBA 01/2023 - 01/2019
3	LigandsIBA 01/2020 - 03/2010
3	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2011
3	Tyrosine Kinase InhibitorsIBA 03/2018 - 09/2012
3	Interleukin-6 (Interleukin 6)IBA 02/2017 - 02/2005
3	Reticulin (Reticular Fiber)IBA 01/2017 - 01/2013
3	PolyphenolsIBA 01/2017 - 01/2013
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2015 - 12/2005
3	Monoclonal AntibodiesIBA 10/2013 - 01/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2011 - 06/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2010 - 10/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 05/2008

Therapy/Procedure

39	Therapeutics 05/2024 - 06/2002
24	Drug Therapy (Chemotherapy) 05/2024 - 04/2003
23	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2023 - 06/2002
17	Stem Cell Transplantation 02/2023 - 08/2002
12	Transplantation 06/2021 - 10/2002
11	Hematopoietic Stem Cell Transplantation 07/2021 - 02/2005
4	Radiotherapy 12/2021 - 01/2008
4	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 08/2021 - 09/2003